Kentucky pharmaceutical maker AllTranz isn't quite done with their first product - a painkillling gel containing a propietary synthetic cannabinoid aimed at osteoathritis treatment. But they aren't resting on their laurels or slouching on their couches. They're busting ahead with another transcendent transdermal - a THC patch for potheads who are trying to cut down. They just got $2+ million from the gummint and almost that much from investors. YOU GUYS ARE WORKING TOO HARD. If you want your products to be taken seriously by serious potheads, you're going to have to start showing signs of using them. So take a pill, or a puff, or a patch, or a gel. Do whatever you gotta do, but I want to see some hardcore abulia by Saturday.
The comments posted here do not reflect the views of the owners of this site.